Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma

Saved in:

Bibliographic Details
Main Authors:	Kenji Inoue, Shoichi Soeda, Goji Tomita
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2014/975429
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antioxidant activity of dorzolamide/timolol fixed combination in neuroprotective therapy in glaucoma
by: N. I. Kurysheva, et al.
Published: (2014-07-01)

Latanoprost/timolol fixed combination in the treatment of primary open-angle glaucoma
by: S. Yu. Petrov, et al.
Published: (2025-03-01)

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy
by: Kazuyoshi Kitamura, et al.
Published: (2018-01-01)

Experience in Application of the Combinations Dorzolamide / Timolol and Brinzolamide / Timolol for the Prevention of Intraocular Hypertension in Patients with Silicone Oil Tamponade of the Vitreal Cavity
by: A. N. Kazennov, et al.
Published: (2024-10-01)

Effectiveness and safety of hypotensive therapy of primary glaucoma with a Russian generic fixed combination of dorzolamide and timolol
by: S. Yu. Petrov, et al.
Published: (2022-09-01)

Evaluation of the Effectiveness of Using a Fixed Combination of Dorzolamide 2.0 % and Timolol 0.5 % in Primary Open-Angle Glaucoma
by: S. S. Khaldeev, et al.
Published: (2024-06-01)

Intracameral prostaglandin implant vs Timolol in open-angle glaucoma or ocular hypertension: a systematic review and meta-analysis
by: Nikhil Sharma, et al.
Published: (2025-07-01)

Efficiency and safety of the fixed latanoprost/ dorzolamide combination in open-angle glaucoma hypotensive treatment
by: V. V. Neroev, et al.
Published: (2023-10-01)

Metabolite patterns of the carbonic anhydrase inhibitors brinzolamide and dorzolamide: potential markers for the route of application
by: Y Jin, et al.
Published: (2025-11-01)

Efficiency and safety of the latanoprost and dorzolamide fixed combination in primary open-angle glaucoma initial hypotensive treatment
by: V. V. Neroev, et al.
Published: (2025-03-01)

Timolol-induced Blepharitis and Conjunctivalization of Meibomian Glands
by: Shirali Gokharu, et al.
Published: (2025-04-01)

Impact of tafluprost and tafluprost/timolol on the thickness of the retina in the macular area
by: N. I. Kurysheva, et al.
Published: (2019-03-01)

Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II
by: N. I. Kurysheva
Published: (2020-12-01)

Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I
by: N. I. Kurysheva
Published: (2020-11-01)

PRESERVATIVE-FREE FIXED COMBINATION OF BIMATOPROST AND TIMOLOL IN THE EVOLUTION OF COMPLIANCE AND TREATMENT EFFECTIVENESS IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA
by: I. A. Loskoutov, et al.
Published: (2018-10-01)

Topical timolol for superficial cutaneous infantile hemangiomas in very preterm infants
by: Matić Aleksandra, et al.
Published: (2021-01-01)

Clinical Experience with Timolol and Brinzolamide Fixed-combination: A Case Series
by: S. V. Yanchenko, et al.
Published: (2025-06-01)

The effectiveness of transferring patients with open-angle glaucoma to therapy with a preservative-free fixed combination of a carbonic anhydrase inhibitor and a prostaglandin analogue
by: S. A. Korotkikh, et al.
Published: (2024-10-01)

Adjunctive antihypertensive therapy of primary glaucoma with a fixed combination drug of 1% brinzolamide and 0.5% timolol: efficacy and safety
by: S. Yu. Petrov, et al.
Published: (2023-07-01)

Determination of related substances of travoprost in travoprost and timolol maleate eye drops by HPLC
by: LI Yujun, et al.
Published: (2025-06-01)

Topical Timolol in the Treatment of Hemodialysis Tunneled Catheter Exit-Site Pyogenic Granuloma
by: Renato A. Caires, et al.
Published: (2025-04-01)

A comparative evaluation of the efficacy and safety of Latanoprost-Optic and Xalatan used as monotherapy and combined with Dorzolamide-Optic for primary open-angle glaucoma under clinical practice conditions
by: D. P. Novikov, et al.
Published: (2023-03-01)

Peptide dendrimer and hyaluronic acid modified nanovesicles for ocular delivery of timolol maleate and siRNA
by: Santoshi Naik, et al.
Published: (2025-07-01)

Latanoprost in the treatment of primary open-angle glaucoma
by: S. Yu. Petrov, et al.
Published: (2024-12-01)

Efficacy, Tolerability and Adverse Effects of Triple Fixed Dose Combination Brimonidine–Brinzolamide–Timolol Ophthalmic Suspension in Primary Open Angle Glaucoma: A Retrospective Study
by: Hina Kounsar, et al.
Published: (2025-04-01)

Effect of Tafluprost and Tafloprost/Timolol on the Optic Nerve Head, Peripapillary and Macular Microcirculation According to OCT-Angiography
by: N. I. Kurysheva, et al.
Published: (2018-07-01)

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS
by: M. V. Protsenko
Published: (2015-03-01)

From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
by: Muhammad Asim Rana, et al.
Published: (2015-01-01)

Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis.
by: Jin-Wei Cheng, et al.
Published: (2012-01-01)

Prostaglandin Analogs and Eupatilin as Treatments for Nephronophthisis
by: Alice Tata, et al.
Published: (2025-08-01)

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France
by: Carlo Lazzaro, et al.
Published: (2022-01-01)

Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
by: Simon Fabian Lerner, et al.
Published: (2017-01-01)

Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities
by: Claudiu T. Supuran
Published: (2022-12-01)

Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
by: Miriam Ana González-Cela-Casamayor, et al.
Published: (2025-12-01)

Initial hypotensive therapy of primary glaucoma with the domestic latanoprost generic: efficacy and safety
by: S. Yu. Petrov, et al.
Published: (2022-01-01)

New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma
by: A. S. Dukhanin, et al.
Published: (2024-06-01)

Efficacy of 0.5% Timolol Maleate versus 0.05% Clobetasol Propionate in Treating Superficial Infantile Hemangioma: A Pilot Randomized Controlled Trial
by: Sunita Singh, et al.
Published: (2025-05-01)

A Machine Learning Platform for Isoform-Specific Identification and Profiling of Human Carbonic Anhydrase Inhibitors
by: Lisa Piazza, et al.
Published: (2025-07-01)

Editorial: Emerging advancements in the carbonic anhydrase field
by: Simona Maria Monti, et al.
Published: (2025-05-01)

Factors Related to Superior and Inferior Hemifield Defects in Primary Open-Angle Glaucoma
by: Remi Takeuchi, et al.
Published: (2019-01-01)